11553788|t|Introduction of human apolipoprotein E4 "domain interaction" into mouse apolipoprotein E.
11553788|a|Human apolipoprotein E4 (apoE4) binds preferentially to lower density lipoproteins, including very low density lipoproteins, and is associated with increased risk of atherosclerosis and neurodegenerative disorders, including Alzheimer's disease. This binding preference is the result of the presence of Arg-112, which causes Arg-61 in the amino-terminal domain to interact with Glu-255 in the carboxyl-terminal domain. ApoE2 and apoE3, which have Cys-112, bind preferentially to high density lipoproteins (HDL) and do not display apoE4 domain interaction. Mouse apoE, like apoE4, contains the equivalent of Arg-112 and Glu-255, but lacks the critical Arg-61 equivalent (it contains Thr-61). Thus, mouse apoE does not display apoE4 domain interaction and, as a result, behaves like human apoE3, including preferential binding to HDL. To assess the potential role of apoE4 domain interaction in atherosclerosis and neurodegeneration, we sought to introduce apoE4 domain interaction into mouse apoE. Replacing Thr-61 in mouse apoE with arginine converted the binding preference from HDL to very low density lipoproteins in vitro, suggesting that apoE4 domain interaction could be introduced into mouse apoE in vivo. Using gene targeting in embryonic stem cells, we created mice expressing Arg-61 apoE. Heterozygous Arg-61/wild-type apoE mice displayed two phenotypes found in human apoE4/E3 heterozygotes: preferential binding to lower density lipoproteins and reduced abundance of Arg-61 apoE in the plasma, reflecting its more rapid catabolism. These findings demonstrate the successful introduction of apoE4 domain interaction into mouse apoE in vivo. The Arg-61 apoE mouse model will allow the effects of apoE4 domain interaction in lipoprotein metabolism, atherosclerosis, and neurodegeneration to be determined.
11553788	16	21	human	Species	9606
11553788	22	39	apolipoprotein E4	Gene	348
11553788	66	71	mouse	Species	10090
11553788	90	95	Human	Species	9606
11553788	96	113	apolipoprotein E4	Gene	348
11553788	115	120	apoE4	Gene	348
11553788	256	271	atherosclerosis	Disease	MESH:D050197
11553788	276	303	neurodegenerative disorders	Disease	MESH:D019636
11553788	315	334	Alzheimer's disease	Disease	MESH:D000544
11553788	509	514	ApoE2	Gene	348
11553788	519	524	apoE3	Gene	348
11553788	620	625	apoE4	Gene	348
11553788	646	651	Mouse	Species	10090
11553788	663	668	apoE4	Gene	348
11553788	787	792	mouse	Species	10090
11553788	815	820	apoE4	Gene	348
11553788	871	876	human	Species	9606
11553788	877	882	apoE3	Gene	348
11553788	955	960	apoE4	Gene	348
11553788	983	998	atherosclerosis	Disease	MESH:D050197
11553788	1003	1020	neurodegeneration	Disease	MESH:D019636
11553788	1045	1050	apoE4	Gene	348
11553788	1075	1080	mouse	Species	10090
11553788	1107	1112	mouse	Species	10090
11553788	1233	1238	apoE4	Gene	348
11553788	1283	1288	mouse	Species	10090
11553788	1360	1364	mice	Species	10090
11553788	1424	1428	mice	Species	10090
11553788	1463	1468	human	Species	9606
11553788	1469	1474	apoE4	Gene	348
11553788	1692	1697	apoE4	Gene	348
11553788	1722	1727	mouse	Species	10090
11553788	1758	1763	mouse	Species	10090
11553788	1796	1801	apoE4	Gene	348
11553788	1848	1863	atherosclerosis	Disease	MESH:D050197
11553788	1869	1886	neurodegeneration	Disease	MESH:D019636
11553788	Association	MESH:D019636	348
11553788	Association	MESH:D000544	348
11553788	Association	MESH:D050197	348

